Concentration and Attentional Deficits in POTS and Other Autonomic Neuropathies

Last updated: June 23, 2023
Sponsor: RWTH Aachen University
Overall Status: Completed

Phase

N/A

Condition

Fast Heart Rate (Tachycardia)

Memory Problems

Heart Disease

Treatment

leg crossing

Clinical Study ID

NCT03681080
17-006
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

People with POTS, autoimmune autonomic neuropathy (AAN), pure autonomic failure (PAF), SFN and Ehlers Danlos Syndrome (EDS) do not only suffer from orthostatic symptoms such as dizziness, headache, neck pain, blurred vision or (pre-) syncope. They also experience deficits in attention and concentration (more precisely deficits in selective perspective, operating speed, executive functions and memory performance) mainly in upright position. Only few studies concerning cognitive impairment in autonomic neuropathies, their frequency, aetiology and therapy exist. Many patients concerned, especially with POTS, report attention deficits and "brain fog" with problems in their everyday life and work, predominantly in upright posture. Specific symptomatic or medical therapies do not exist. Medical treatment with Modafinil is discussed and part of a current study at Vanderbilt Autonomic Dysfunction Centre (1-5). The investigators want to investigate if problems of concentration, attention and/or cognitive dysfunction exist in people with POTS, AAN, SFN and EDS compared to healthy controls (HC). Thus the investigators use detailed clinical, autonomic and neuropsychological tests in different body positions (lying, sitting and standing) as also acute therapy (leg crossing).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • AAN, SFN, hEDS, POTS or healthy control
  • diagnosis in our clinic on the basis of anamnesis, clinical data as neurologicalexamination, tilt table, QST, skin biopsy, norepinephrine values, vitamine B12,antibodies

Exclusion

Exclusion Criteria: for all participants

  • pregnancy, nonage,severe heart insufficiency, deep brain Stimulation, pace maker, drugconsumption, large fibre polyneuropathy for controls
  • medication influencing blood pressure, psychiatric disease, synkopes or dizziness,neurological disorders esp. polyneuropathy, dementia, vitamine or iron deficiency

Study Design

Total Participants: 110
Treatment Group(s): 1
Primary Treatment: leg crossing
Phase:
Study Start date:
April 01, 2017
Estimated Completion Date:
May 30, 2023

Study Description

We are still recruting healthy controls and patients with autoimmune autonomic neuropathy in order to perform titl table examination and laboratory testing on day one, ono an empty stomach, without morning medication. Cognitive testing is performed on day two after randomization in three groups: lying, standing and standing with legs crossed.

Connect with a study center

  • University Hospital, RWTH Aachen

    Aachen, Nordrhein Westfalen 52074
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.